Apellis Pharmaceuticals
APLS
#3529
Rank
โ‚น240.72 B
Marketcap
โ‚น1,918
Share price
-2.09%
Change (1 day)
-59.61%
Change (1 year)

Apellis Pharmaceuticals (APLS) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : โ‚น55.90 Billion

According to Apellis Pharmaceuticals's latest financial reports the company's total liabilities are โ‚น55.90 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Apellis Pharmaceuticals - Total liabilities on balance sheet (from 2014 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น56.31 B13.85%
2023-12-31โ‚น49.46 B1.26%
2022-12-31โ‚น48.85 B-3.92%
2021-12-31โ‚น50.84 B-8.04%
2020-12-31โ‚น55.29 B118.4%
2019-12-31โ‚น25.31 B750.7%
2018-12-31โ‚น2.97 B40.43%
2017-12-31โ‚น2.11 B756.96%
2016-12-31โ‚น0.24 B16.28%
2015-12-31โ‚น0.21 B210.26%
2014-12-31โ‚น68.54 M63.9%
2013-12-31โ‚น41.82 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น2.64 B-95.28%๐Ÿ‡บ๐Ÿ‡ธ USA